A Pilot Trial of a Self-Management Intervention for Breathlessness in Lung Cancer
Lung cancer is common worldwide and is a leading cause of death. Breathlessness (dyspnea or
shortness of breath) is a highly prevalent clinical problem in lung cancer, developing early
in 25-50% of patients due to advanced stage at presentation. It persists in 60% of
survivors' post-lung resection and worsens with progressive disease with rates as high as
90% reported in the final months of life. Breathlessness is associated with a high degree of
unpleasantness, negatively impacts on daily functioning, and multiple domains of quality of
life, triggers fear and anxiety in patients and their family, and contributes to symptom
specific and psychological distress. It is also costly to the health system as it
contributes to urgent care use and hospitalization. The purpose of this pilot trial is to
evaluate feasibility and acceptability of a self-management intervention for breathlessness
in lung cancer.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Perceived severity of breathlessness
Measured by Numeric Rating Scale for breathlessness intensity.
8 weeks
No
Doris Howell, RN PhD
Principal Investigator
Princess Margaret Hospital, University Health Network
Canada: Ethics Review Committee
Breathlessness Pilot
NCT01585883
May 2012
November 2013
Name | Location |
---|